Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 5/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.72 |
| ▸ | NPC1 | O15118 | 2/20 | 0.72 |
| ▸ | RAB9A | P51151 | 2/20 | 0.72 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.71 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.71 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.71 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.65 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.61 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.61 |
| ▸ | KDM1A | O60341 | 1/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.58 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.58 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.58 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24755230 | 0.87 | HDAC6 (0.75) | SNCAMEN1KMT2ANPC1RAB9A | |
| SCHEMBL1164730 | 0.86 | HDAC6 (0.74) | SNCAMEN1KMT2ANPC1RAB9A | |
| SCHEMBL1165020 | 0.86 | HDAC1 (0.73) | SNCAMEN1KMT2ANPC1RAB9A | |
| SCHEMBL1164962 | 0.85 | HDAC6 (0.78) | SNCAMEN1KMT2ANPC1RAB9A | |
| SCHEMBL3439433 | 0.85 | HDAC1 (0.69) | SNCAMEN1KMT2ANPC1RAB9A | |
| SCHEMBL1165015 | 0.85 | HDAC1 (0.69) | SNCAMEN1KMT2ANPC1RAB9A | |
| SCHEMBL2128338 | 0.83 | SNCA (0.57) | SNCAMEN1KMT2ANPC1RAB9A | |
| SCHEMBL1165505 | 0.83 | HDAC6 (1.00) | SNCAMEN1KMT2ANPC1RAB9A | |
| SCHEMBL25055360 | 0.82 | MEN1 (0.80) | SNCAMEN1KMT2ANPC1RAB9A | |
| SCHEMBL1165557 | 0.81 | HDAC6 (0.64) | SNCAMEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220401418-A1 | TREATMENT OF MALARIA USING HISTONE DEACETYLASE (HDAC) INHIBITORS | FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) | 2022-12-22 | — | — | US | disclosed |
| EP-2451790-A1 | HISTONE DEACETYLASE INHIBITORS | Anthem Biosciences Private Limited (IN) | 2012-05-16 | — | — | EP | disclosed |
| US-20120101099-A1 | HISTONE DEACETYLASE INHIBITORS | ANTHEM BIOSCIENCES PRIVATE LIMITED (IN) | 2012-04-26 | — | — | US | disclosed |
| US-20120101099-A1 | HISTONE DEACETYLASE INHIBITORS | ANTHEM BIOSCIENCES PRIVATE LIMITED (IN) | 2012-04-26 | — | — | US | disclosed |
| US-20120101099-A1 | HISTONE DEACETYLASE INHIBITORS | ANTHEM BIOSCIENCES PRIVATE LIMITED (IN) | 2012-04-26 | — | — | US | disclosed |
| WO-2011021209-A1 | HISTONE DEACETYLASE INHIBITORS | PORTSMOUTH TECHNOLOGIES LLC (US) | 2011-02-24 | — | — | WO | disclosed |
| WO-2011021209-A1 | HISTONE DEACETYLASE INHIBITORS | PORTSMOUTH TECHNOLOGIES LLC (US) | 2011-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220401418-A1 | TREATMENT OF MALARIA USING HISTONE DEACETYLASE (HDAC) INHIBITORS | HDAC5, HDAC4, HDAC3 | SNCA 4829/4885MEN1 4475/4885KMT2A 31/4885 |
| US-20120101099-A1 | HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC3, HDAC11 | SNCA 4841/4885MEN1 3069/4885KMT2A 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.